firdapse - Søg

Copilot

Din daglige ledsager med kunstig intelligens

Circa 31.200 resultater

europa.eu
https://www.ema.europa.eu/en/medicines/human/EPAR/firdapse-pr…
Firdapse (previously Zenas) | European Medicines Agency
WEBFirdapse is used to treat the symptoms of Lambert-Eaton myasthenic syndrome (LEMS) in adults. LEMS is a disease in which patients have muscle weakness because of a failure …
Udforsk videre
Firdapse, INN-amifampridine - European Medicines Agency
ema.europa.eu
(PDF) Amifampridine phosphate (Firdapse®) is Effective and …
researchgate.net
BioMarin Launches Firdapse in the European Union - PR …
prnewswire.com
How FIRDAPSE Works | FIRDAPSE® (amifampridine)
firdapse.com
FIRDAPSE 10mg tablet - Patient Information Leaflet (PIL) - …
medicines.org.uk
Anbefalet til dig baseret på, hvad der er populært • Feedback
Farmacotherapeutisch Kompas
https://www.farmacotherapeutischkompas.nl/bladeren/preparaattekst…
amifampridine - Farmacotherapeutisch Kompas
WEBamifampridine vergelijken met een ander geneesmiddel.. Advies. Amifampridine is middel van eerste keus bij de symptomatische behandeling van LEMS. De Commissie geeft de …
Billeder af Firdapse

bing.com/images
catalystpharma.com
Current Approved Product - catalystpharma.com
apotek1.no
Firdapse 10 mg tabletter 100 stk - Apotek 1
everydayhealth.com
Firdapse (Amifampridine) - Side Effects, Interactions, Uses, Dosage ...
theindianpharma.com
Firdapse (Amifampridine) Tablets Uses, Side Effects, Dosage +91 9310090915.
pidrug.com
肌无力综合征新药！FIRDAPSE（amifampridine）中文说明书-价格-适应症-不良反应及注意事项-香港济民药业
ilacfiyati.com
FIRDAPSE 10 MG 100 TABLETS - Fiyatı, Nedir, Ne işe yarar, Nasıl ...
thescipreneur.com
FDA Approved Firdapse® :First Treatment of Lambert-Eaton Myasthenic ...
Se alle billeder
firdapse.com
https://firdapse.com
FIRDAPSE® (amifampridine) | Official Patient Site
WEBFIRDAPSE is a prescription medicine used to treat Lambert-Eaton myasthenic syndrome (LEMS) in people 6 years of age or older. It is not known if FIRDAPSE is safe or …
Udforsk videre
FDA approves first treatment for Lambert-Eaton …
fda.gov
Firdapse: Package Insert - Drugs.com
drugs.com
Anbefalet til dig baseret på, hvad der er populært • Feedback
Apotheek.nl
https://www.apotheek.nl/producten/firdapse
amifampridine | Apotheek.nl
WEBFirdapse De officiële bijsluiter van de verschillende producten van amifampridine vindt u op: Geneesmiddeleninformatiebank van het CBG. Heb ik een recept nodig?
Mærker:
FIRDAPSE
Amifampridine
Folk spørger også om
Is Firdapse authorised in the European Union?
This medicine is authorised for use in the European Union This is a summary of the European public assessment report (EPAR) for Firdapse.
Firdapse (previously Zenas) | European Medicines Agency
ema.europa.eu
What are the side effects of Firdapse?
The most common side effects reported with Firdapse are paraesthesia (unusual sensations like pins and needles) and gastro-intestinal disorders such as epigastralgia (pain around the upper part of the stomach), diarrhoea, nausea (feeling sick) and abdominal pain (stomach ache).
Firdapse, INN-Amifampridine - European Medicines Agency
ema.europa.eu
Is Firdapse a rare disease?
LEMS is a disease in which patients have muscle weakness because of a failure of the nerves to transmit electrical impulses to the muscles. Because the number of patients with LEMS is low, the disease is considered ‘rare’, and Firdapse was designated an ‘orphan medicine’ (a medicine used in rare diseases) on 18 December 2002.
Firdapse, INN-Amifampridine - European Medicines Agency
ema.europa.eu
How does Firdapse work?
The active substance in Firdapse, amifampridine, is a potassium channel blocker, which prevents charged potassium particles from leaving the nerve cells. This prolongs the period of depolarisation, allowing more time for the nerves to release acetylcholine and so stimulate the muscles to contract. How has Firdapse been studied?
Firdapse, INN-Amifampridine - European Medicines Agency
ema.europa.eu
Feedback
Wikipedia
https://en.wikipedia.org/wiki/Amifampridine
Amifampridine - Wikipedia
Overview
History
Medical uses
Contraindications
Adverse effects
Interactions
Pharmacology
Chemistry
The development of amifampridine and its phosphate has brought attention to orphan drug policies that grant market exclusivity as an incentive for companies to develop therapies for conditions that affect small numbers of people.
Amifampridine, also called 3,4-DAP, was discovered in Scotland in the 1970s, and doctors in Sweden first showed its use in LEMS in the 1980s.
Wikipedia · Tekst under CC-BY-SA-licens
- Anslået læsetid: 9 min
pro.medicin.dk
https://pro.medicin.dk/Medicin/Praeparater/6542
Firdapse® - information til sundhedsfaglige - Medicin.dk
WEBInitialdosis. 15 mg dgl. fordelt på 3-4 doser. Dosis kan øges med 5 mg hver 4. eller 5. dag. Højst 20 mg pr. dosis og højst 60 mg dgl. Bemærk: Tabletterne tages med et glas vand. …
min.medicin.dk
https://min.medicin.dk/Medicin/Praeparater/6542
Hvad er Firdapse®? - Find information på Medicin.dk
WEBFirdapse® anvendes ved en bestemt form for muskelsvind (Lambert-Eaton syndrom), der skyldes dannelse af antistoffer mod nervernes forbindelse til musklerne. Behandlingen …
europa.eu
https://www.ema.europa.eu/en/documents/overview/firdap… · PDF-fil
Firdapse, INN-Amifampridine - European Medicines Agency
WEBFirdapse is used to treat the symptoms of Lambert-Eaton myasthenic syndrome (LEMS) in adults. LEMS is a disease in which patients have muscle weakness because of a …
firdapsehcp.com
https://firdapsehcp.com/about-firdapse
About FIRDAPSE | FIRDAPSE® (amifampridine)
WEBLearn more about FIRDAPSE® (amifampridine), the recommended first-line treatment for adults diagnosed with Lambert-Eaton myasthenic syndrome (LEMS). Please visit the …
Mærker:
FIRDAPSE
Amifampridine
firdapsehcp.com
https://firdapsehcp.com/about-lems/lems-facts
LEMS Facts | FIRDAPSE® (amifampridine)
WEBFIRDAPSE is a potassium channel blocker indicated for the treatment of Lambert-Eaton myasthenic syndrome (LEMS) in adults and pediatric patients 6 years of age and older.
Mærker:
FIRDAPSE
Amifampridine
Sideinddeling
- 1
- 2
- Næste

Administrer indstillinger for cookies

Vi bruger også nødvendige cookies, disse kan ikke slukkes

Analyse:

Vi tillader muligvis tredjeparter at bruge analysecookies til at forstå, hvordan du bruger vores websteder, så vi kan gøre dem bedre, og tredjeparterne kan udvikle og forbedre deres produkter, som de kan bruge på websteder, der ikke ejes eller drives af Microsoft.

Fra

Sociale medier:

Vi bruger cookies på sociale medier til at vise dig indhold baseret på dine sociale medie-profiler og din aktivitet på vores websteder. De bruges til at forbinde din aktivitet på vores websteder med dine profiler på sociale medier, så det indhold, du ser på vores websteder og på sociale medier, bedre afspejler dine interesser.

Fra

Reklame:

Aktivér brugen af cookies for at gøre annoncering mere relevant, og for at understøtte indhold af høj kvalitet på dette websted. Hvis du ikke tillader denne brug, kan annoncer, der vises til dig, være mindre relevante.

Fra

Gem Indstillinger